Vitamin E suppresses the development of murine aids through the inhibition of nuclear factor-kappa B expression

Nutrition Research

Volumn 20, Issue 8, 2000, Pages 1163-1171

  Hamada, Masafumi ^a   Yamamoto, Shigeru ^a   Kishino, Yasuo ^b   Moriguchi, Satoru ^c  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^c YAMAGUCHI PREFECTURAL UNIVERSITY   (Japan)

Author keywords

AZT; Interferon ; Murine AIDS; NF B; Tumor necrosis factor ; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID PEROXIDE; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; FEMALE; GENE EXPRESSION; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RODENT DISEASE; SPLEEN LYMPHOCYTE; VITAMIN INTAKE;

ANIMALIA; MURINAE; RODENTIA; UNIDENTIFIED RETROVIRUS;

EID: 0033840126     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(00)00198-6     Document Type: Article

References (28)

1. Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS
2. Murine models for acquired deficiency syndrome
3. Nucleosides. 5. The monomesylates of 1-(2'-deoxy-beta-lyxofuranosyl) thymidine
4. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial
5. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial
6. Developmental therapeutics and the acquired immunodeficiency syndrome
7. Potential of azidothymidine to activate the HIV-1 promoter
8. Micronutrient status and human immunodeficiency virus (HIV) infection
9. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1
10. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells
11. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus
12. Vitamin E supplementation normalizes immune dysfunction in murine AIDS induced by LP-BM5 retrovirus infection
13. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus
14. Vitamin E and alpha-lipoate: Role in antioxidant recycling and activation of the NF-kappa B transcription factor
15. Is vitamin E supplementation a useful agent in AIDS therapy?
16. Modulation of immune function and cytokine production by various levels of vitamin E supplementation during murine AIDS
17. Increased therapeutic efficacy of zidovudine in combination with vitamin E
18. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test
19. Determination of serum tocopherol by high-performance liquid chromatography
20. Membrane association of a 36,000-dalton substrate for tyrosine phosphorylation in chicken embryo fibroblasts transformed by avian sarcoma viruses
21. Nutritional status and immune responses in mice with murine AIDS are normalized by vitamin E supplementation
22. Long-term dietary vitamin E retards development of retrovirus-induced disregulation in cytokine production
23. Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate
24. Macrophage function in simian AIDS. Killing defects in vitro are independent of macrophage infection, associated with alterations in Th phenotype, and reversible with IFN-γ
25. Stimulation of free radical generation in human leukocytes by various agents including tumor necrosis factor is a calmodulin dependent process
26. Effect of 3' azidothymidine administered in drinking water or by continuous infusion on the development of MAIDS
27. ZDV delays but does not prevent the transmission of MAIDS by LP-BM5 MuLV-infected macrophage-monocytes
28. Zidovudine (AZT) reduces virus titer, retards immune dysfunction, and prolongs survival in the LP-BM5 murine induced immunodeficiency model